Mazdutide
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Innovent · Phase 2 · Completed · Enrollment 328
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| IBI362 high dose | n/r | n/r | n/r | n/r | n/r |
| IBI362 low dose | n/r | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r | n/r |
| IBI362 moderate dose | n/r | n/r | n/r | n/r | n/r |
| IBI362 extra high dose | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.